SOPREFERENCE OUTLINE

Veterinary Active Substance Distribution Procedure

Distribution procedure under the veterinary instrument, which is separate from its human counterpart because the applicable law follows intended use rather than the molecule. Establishes intended use first, checks that registrations are veterinary-specific rather than inherited from a human-side authorisation, controls storage for the material actual risk profile, verifies customer entitlement, and plans recall with treated animals and the food chain in view. Maps to Implementing Regulation (EU) 2021/1280.

What a template is not

A template is a document baseline to adapt inside your own quality system. SPEQ does not approve, validate, or take responsibility for what you issue from it, and using one is not evidence of compliance.

CHECKING ACCESS

Checking your Professional access…

REGULATIONS MAPPED
Impl. Reg. (EU) 2021/1280
DOCUMENT TYPE
SOP
LAST UPDATED
August 2026
PURPOSE

Active substances for veterinary medicinal products carry their own EU distribution requirements. The material may be chemically identical to the human-use substance and arrive from the same manufacturer, but the applicable instrument follows intended use, not the molecule. That makes this a scope trap with no technical signal attached: nothing about the drum tells you which regime applies, so the determination must be made deliberately and recorded.

What's Inside

Intended-use determination, recorded explicitly, confirming which instrument governs this material and this consignment
Registration and authorisation standing checked as veterinary-specific rather than inherited from a human-side authorisation
Traceability to the manufacturing site, preserved through every broker and intermediate in the chain
Storage and transport controls set to the material’s actual risk profile at bulk scale
Customer entitlement to receive veterinary active substances, verified for the category actually being supplied
Complaint and return handling for material already incorporated into a veterinary medicinal product
Recall planning reaching treated animals and, for food-producing species, the human food chain

How to Use It

1Establish intended use first and record the determination, because this scope trap carries no technical signal to catch it
2Do not infer veterinary standing from a human-side authorisation, since holding one does not confer the other
3Verify the registration covers the specific activity you perform, not merely the company name and the site address
4Add contamination controls where bulk veterinary actives sit in facilities designed for a different risk profile
5Check customer entitlement for the category supplied, since entitlement for one veterinary category is not entitlement for all
6Plan recall past the manufacturing customer: treated food-producing animals carry residues into the human food chain
DOCUMENT CONTENTS

The full section structure of this template — every section and sub-section, so you can use it as a baseline for your own site document.

Document Control
Document InformationApproval SignaturesRevision HistoryDistribution List
1Intended Use Determines the Instrument
2Registration and Authorisation Standing
3Traceability and Supply Chain
4Storage and Transport for the Actual Material
5Customer Entitlement
6Recall Planning With the Food Chain in View
REGULATORY CONTEXT

Commission Implementing Regulation (EU) 2021/1280 lays down measures on good distribution practice for active substances used as starting materials in veterinary medicinal products, and is a separate instrument from the human-use active substance guidelines. It does not classify your material for you; intended use is a determination your organisation makes, records and defends, and it can differ consignment by consignment from one manufacturer. The procedure structure and the food-chain framing of recall are SPEQ practitioner synthesis.

MAPPED STANDARDS
Impl. Reg. (EU) 2021/1280
Browse the standards catalog →